一品红(300723.SZ)子公司获左卡尼汀口服溶液注册证书

Core Viewpoint - The company Yipinhong (300723.SZ) has received approval from the National Medical Products Administration for its product, L-Carnitine Oral Solution, which is indicated for the treatment of primary systemic carnitine deficiency [1] Group 1 - Yipinhong's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has been granted a drug registration certificate for L-Carnitine Oral Solution [1] - The indication for L-Carnitine Oral Solution is specifically for treating primary systemic carnitine deficiency [1]